Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « Keywords » - entrée « Chloroquine (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Chloroquine (administration & dosage) < Chloroquine (adverse effects) < Chloroquine (analogs & derivatives)  Facettes :

List of bibliographic references indexed by Chloroquine (adverse effects)

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000060 (2020) M. Roustit [France] ; R. Guilhaumou [France] ; M. Molimard [France] ; M-D Drici [France] ; S. Laporte [France] ; J-L Montastruc [France]Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.
000061 (2020) Isabelle Lacroix [France] ; Justine Bénévent [France] ; Christine Damase-Michel [France]Chloroquine and hydroxychloroquine during pregnancy: What do we know?
000065 (2020) Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France]"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
000A31 (2020) Franck Touret [France] ; Xavier De Lamballerie [France]Of chloroquine and COVID-19.
001278 (2020) James A. Watson [Thaïlande, Royaume-Uni] ; Joel Tarning [Thaïlande, Royaume-Uni] ; Richard M. Hoglund [Thaïlande, Royaume-Uni] ; Frederic J. Baud [France] ; Bruno Megarbane [France] ; Jean-Luc Clemessy [France] ; Nicholas J. White [Thaïlande, Royaume-Uni]Concentration-dependent mortality of chloroquine in overdose.
001360 (2020) M. Lecuit [France]Chloroquine and COVID-19, where do we stand?
001579 (2020) Hervé Javelot [France] ; Wissam El-Hage [France] ; Guillaume Meyer [France] ; Guillaume Becker [France] ; Bruno Michel [France] ; Coraline Hingray [France]COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Chloroquine (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Chloroquine (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Chloroquine (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021